samedan logo
 
 
spacer
home > ict > autumn 2017 > keeping track
PUBLICATIONS
International Clinical Trials

Keeping Track

As the global pharmaceutical industry implements serialisation to meet governmental regulatory requirements, other opportunities exist for companies to realise business benefits. The main driver for serialisation is to provide greater integrity to the supply chain, but other meaningful advantages can also be obtained.

Combatting Counterfeits

In addition to tightening up the supply chain and channels of trade, serialisation can provide great efficiencies for processing shipments and knowing what specific packages are included in shipments down to the lowest saleable unit. Tracking information can be updated continuously and provided to brand owners and supply chain partners on dashboards or on mobile applications.

These developments in enhanced track and trace can be employed to more quickly and accurately detect diversion of product to unauthorised regions. To combat counterfeiting, new authentication technologies now exist for linking serial numbers to security features that are unique to each package to detect possible replication of serial numbers by counterfeiters.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Steve Wood is the President and Chief Executive Officer (CEO) of Covectra and holds a Bachelor of Science degree from the US Naval Academy and an MBA from Yale, US. He has over 25 years of experience in processing and packaging machinery, pharma security technologies and integrated systems. Steve is the co-founder/CEO of five different companies and is currently serving as Director of PharmoRx Therapeutics and MedSentry.
spacer
Steve Wood
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mologic Signs Agreements with Medisur and Peripal to Distribute PERiPLEX POC Diagnostic in Europe

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®, a rapid point-of-care (POC) test for the detection of infection in patients on peritoneal dialysis (PD). Both companies are specialists in the development and distribution of products which enable patient self-management and will supply PERiPLEX as part of a highly complementary product portfolio in key European markets including France, Germany, Italy, The Netherlands, Austria and Switzerland.
More info >>

White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>

 
Industry Events

Symposium on Digitalization and Big Data in Biotech and Pharma

6 June 2018, ETH Zurich, Institute for Chemical and Bioengineering, Vladimir-Prelog-Weg 1

The Symposium on Digitalization and Big Data in Biotech & Pharma will bring together experts and key stakeholders from industry and academia to discuss and current digital innovations and technological trends in the pharmaceutical sector.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement